The novel pharmacological strategy for treatment of functional dyspepsia with reflux symptoms using acotiamide

被引：0
|
作者：
Yamashita, Hiroshi [1 ]
Hongo, Hitoshi [2 ]
Okada, Akihiko
机构：
[1] Osakafu Saiseikai Nakatus Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan
[2] Fujita Gastrointestinal Hosp, Takatsuki, Osaka, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-0267
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [21] Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach
    Yoshii, Kazuyoshi
    Iikura, Minami
    Hirayama, Masamichi
    Toda, Ryoko
    Kawabata, Yoshihiro
    PHARMACEUTICAL RESEARCH, 2016, 33 (02) : 292 - 300
  • [22] Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach
    Kazuyoshi Yoshii
    Minami Iikura
    Masamichi Hirayama
    Ryoko Toda
    Yoshihiro Kawabata
    Pharmaceutical Research, 2016, 33 : 292 - 300
  • [23] Pattern of symptoms in functional dyspepsia: Predictors of a response to treatment?
    Holtmann, G
    NeufangHuber, J
    Talley, NJ
    Goebell, H
    GASTROENTEROLOGY, 1996, 110 (04) : A680 - A680
  • [24] PHYSIOLOGICALLY-BASED PHARMACOKINETIC AND PHARMACODYNAMIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ACOTIAMIDE, A NOVEL GASTROPROKINETIC AGENT FOR THE TREATMENT OF FUNCTIONAL DYSPEPSIA, IN RAT STOMACH
    Yoshii, Kazuyoshi
    Iikura, Minami
    Hirayama, Masamichi
    Toda, Ryoko
    Mera, Yukinori
    Kawabata, Yoshihiro
    DRUG METABOLISM REVIEWS, 2014, 45 : 231 - 231
  • [25] Capsaicin: A Novel Approach to the Treatment of Functional Dyspepsia
    Li, Tianxu
    Wan, Yuan
    Meng, Yaqi
    Zhou, Qiaoyun
    Li, Bin
    Chen, Yijie
    Wang, Ling
    MOLECULAR NUTRITION & FOOD RESEARCH, 2023, 67 (09)
  • [26] Novel concepts in the pathophysiology and treatment of functional dyspepsia
    Wauters, Lucas
    Talley, Nicholas J.
    Walker, Marjorie M.
    Tack, Jan
    Vanuytsel, Tim
    GUT, 2020, 69 (03) : 591 - 600
  • [27] LIM kinase inhibitor: A novel pharmacological strategy in the treatment of mixed symptoms in mixed LUTS?
    Yu, Q.
    Cen, P.
    Lan, H.
    Zhou, X.
    Huang, R.
    Zeng, G.
    EUROPEAN UROLOGY, 2024, 85 : S2109 - S2109
  • [28] Acotiamide (Z-338), a Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, Enhances Gastric Motility Without Prolonging QT Interval in Dogs and Rats
    Matsunaga, Yugo
    Tanaka, Takao
    Kawachi, Masanao
    Nagahama, Kenji
    Ito, Katsunori
    Hori, Yuko
    Eta, Runa
    Takei, Mineo
    GASTROENTEROLOGY, 2011, 140 (05) : S602 - S602
  • [29] Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan
    Yamawaki, H.
    Futagami, S.
    Kawagoe, T.
    Maruki, Y.
    Hashimoto, S.
    Nagoya, H.
    Sato, H.
    Kodaka, Y.
    Gudis, K.
    Akamizu, T.
    Sakamoto, C.
    Iwakiri, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (07): : 1037 - 1047
  • [30] Drug treatment and novel therapies in patients with functional dyspepsia
    Ghoshal, Uday C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 15 - 15
12345